Use of conventional surfactant media as surrogates for FaSSIF in simulating in vivo dissolution of BCS class II drugs
- 15 February 2011
- journal article
- Published by Elsevier in European Journal of Pharmaceutics and Biopharmaceutics
- Vol. 78 (3) , 531-538
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Using biorelevant dissolution to obtain IVIVC of solid dosage forms containing a poorly-soluble model compoundEuropean Journal of Pharmaceutics and Biopharmaceutics, 2008
- Designing biorelevant dissolution tests for lipid formulations: Case example – Lipid suspension of RZ-50European Journal of Pharmaceutics and Biopharmaceutics, 2008
- When poor solubility becomes an issue: From early stage to proof of conceptEuropean Journal of Pharmaceutical Sciences, 2007
- Biorelevant dissolution media as a predictive tool for glyburide a class II drugEuropean Journal of Pharmaceutical Sciences, 2006
- In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution mediaEuropean Journal of Pharmaceutical Sciences, 2005
- Solubilization of Drugs by Physiological Mixtures of Bile SaltsPharmaceutical Research, 2002
- In vitro assessment of oral lipid based formulationsAdvanced Drug Delivery Reviews, 2001
- Biorelevant Dissolution Testing to Predict the Plasma Profile of Lipophilic Drugs After Oral AdministrationPharmaceutical Research, 2001
- Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II DrugsPharmaceutical Research, 1998
- A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo BioavailabilityPharmaceutical Research, 1995